BE640817A - - Google Patents
Info
- Publication number
- BE640817A BE640817A BE640817A BE640817A BE640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A BE 640817 A BE640817 A BE 640817A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242646A US3272824A (en) | 1962-12-06 | 1962-12-06 | 4-amino-6, 7-di(lower) alkoxyquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE640817A true BE640817A (de) | 1964-04-01 |
Family
ID=22915626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE640817A BE640817A (de) | 1962-12-06 | 1963-12-04 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3272824A (de) |
| AT (1) | AT248437B (de) |
| BE (1) | BE640817A (de) |
| BR (1) | BR6355254D0 (de) |
| CH (1) | CH439290A (de) |
| DK (1) | DK107024C (de) |
| ES (1) | ES292176A1 (de) |
| FI (1) | FI41554B (de) |
| GB (1) | GB1010254A (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1035777A (en) * | 1963-08-20 | 1966-07-13 | Bellon Labor Sa Roger | Isoquinoline derivatives |
| FR6103M (de) * | 1967-02-22 | 1968-06-10 | ||
| US3502681A (en) * | 1968-04-10 | 1970-03-24 | Roussel Uclaf | 7- or 8-chloro-4-phenylamino-chloroquinolines |
| US3668207A (en) * | 1970-01-22 | 1972-06-06 | Ciba Geigy Corp | 2-amino-4-aryl-quinolines |
| US3856796A (en) * | 1972-04-19 | 1974-12-24 | Sandoz Ag | Hydroxyalkyl-substituted-amino-quinolines and nitrates thereof |
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| US4656174A (en) * | 1982-07-24 | 1987-04-07 | Pfizer Inc. | Quinoline therapeutic agents |
| US4771052A (en) * | 1987-02-05 | 1988-09-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines and their use as hypotensive agents |
| USRE37650E1 (en) | 1991-05-10 | 2002-04-09 | Aventis Pharmacetical Products, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| US5714493A (en) * | 1991-05-10 | 1998-02-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| JPH05213884A (ja) * | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| KR100567649B1 (ko) * | 1996-09-25 | 2006-04-05 | 아스트라제네카 유케이 리미티드 | 혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체 |
| US6159978A (en) | 1997-05-28 | 2000-12-12 | Aventis Pharmaceuticals Product, Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| MXPA03010565A (es) | 2001-05-21 | 2004-03-02 | Hoffmann La Roche | Derivados de quinolina como ligandos para receptor del neuropeptido y. |
| US6787558B2 (en) * | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| US20070197538A1 (en) * | 2004-10-07 | 2007-08-23 | Mark Nesbit | Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| KR20180086187A (ko) | 2015-10-05 | 2018-07-30 | 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2555943A (en) * | 1947-06-28 | 1951-06-05 | Sterling Drug Inc | Dihalo-4-(aliphatic tertiaryamino-alkylamino)quinolines |
| US2940976A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-(lower-alkyl)-4-(quaternary-ammonium-alkylimino)-1, 4-dihydroquinolines |
| US2940974A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-substituted-4-[(tertiary-or secondary-amino)-alkylimino]-1, 4-dihydroquinolines |
| US3002001A (en) * | 1958-04-03 | 1961-09-26 | Sterling Drug Inc | 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation |
-
1962
- 1962-12-06 US US242646A patent/US3272824A/en not_active Expired - Lifetime
-
1963
- 1963-10-02 GB GB38781/63A patent/GB1010254A/en not_active Expired
- 1963-10-03 ES ES292176A patent/ES292176A1/es not_active Expired
- 1963-11-29 DK DK559363AA patent/DK107024C/da active
- 1963-12-04 FI FI2401/63A patent/FI41554B/fi active
- 1963-12-04 BE BE640817A patent/BE640817A/xx unknown
- 1963-12-05 CH CH1498063A patent/CH439290A/de unknown
- 1963-12-06 BR BR155254/63A patent/BR6355254D0/pt unknown
- 1963-12-06 AT AT977363A patent/AT248437B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| US3272824A (en) | 1966-09-13 |
| FI41554B (de) | 1969-09-01 |
| ES292176A1 (es) | 1964-02-16 |
| CH439290A (de) | 1967-07-15 |
| GB1010254A (en) | 1965-11-17 |
| BR6355254D0 (pt) | 1973-07-19 |
| AT248437B (de) | 1966-07-25 |
| DK107024C (da) | 1967-04-17 |